Positive affect and inflammation during radiation treatment for breast and prostate cancer

Brain, Behavior, and Immunity

Volumn 23, Issue 8, 2009, Pages 1068-1072

  Sepah, Saviz C ^a   Bower, Julienne E ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cytokines; Interleukin 1 ; Interleukin 6; Positive affect; Prostate cancer; Radiation treatment

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AFFECT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SKIN IRRITATION; SKIN REDNESS; SOCIAL PSYCHOLOGY; TISSUE REPAIR;

ADULT; AFFECT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOASSAY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY);

EID: 72649100801     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.06.149     Document Type: Article

References (43)

1. Arpin D., et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J. Clin. Oncol. 23 (2005) 8748-8756
2. Aziz N., Nishanian P., and Fahey J.L. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin. Diagn. Lab. Immunol. 5 (1998) 755-761
3. Aziz N., Nishanian P., Mitsuyasu R., Detels R., and Fahey J.L. Variables that affect assays for plasma cytokines and soluble activation markers. Clin. Diagn. Lab. Immunol. 6 (1999) 89-95
4. Barcellos-Hoff M.H. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat. Res. 150 (1998) S109-S120
5. Bower J.E. Behavioral symptoms in patients with breast cancer and survivors. J. Clin. Oncol. 26 (2008) 768-777
6. Bower J.E., Low C.A., Moskowitz J.T., Sepah S., and Epel E. Benefit finding and physical health: positive psychological changes and enhanced allostasis. Soc. Pers. Psychol. Compass 2 (2008) 223-244
7. Bower J.E., Meyerowitz B.E., Desmond K.A., et al. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann. Behav. Med. 29 (2005) 236-245
8. Cesari M., et al. Inflammatory markers and onset of cardiovascular events. Circulation 108 (2003) 2317-2322
9. Christiansen H., Saile B., Hermann R.M., Rave-Frank M., Hille A., Schmidberger H., Hess C.F., and Ramadori G. Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer. J. Cancer Res. Clin. Oncol. 133 (2007) 297-304
10. Cohen S., Alper M., Doyle W.J., Treanor J.J., and Turner R.B. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom. Med. 68 (2006) 809-815
11. Costanzo E.S., Lutgendorf S.K., Kohut M.L., Nisly N., Rozeboom K., Spooner S., Benda J., and McElhaney J.E. Mood and cytokine response to influenza virus in older adults. J. Gerontol. 12 (2004) 1328-1333
12. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
13. Doyle W.J., Gentile D.A., and Cohen S. Emotional style, nasal cytokines, and illness expression after experimental rhinovirus exposure. Brain Behav. Immun. 20 (2006) 175-181
14. Glaser R., and Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5 (2005) 243-251
15. Hagemann T., Balkwell F., and Lawrence T. Inflammation and cancer: a double-edged sword. Cancer Cell 12 (2007) 300-301
16. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., Heimovitz H., Cohen H.J., and Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106 (1999) 506-512
17. Hartsell W.F., Scott C.B., Dundas G.S., Mohiuddin M., Meredith R.F., Rubin P., et al. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Am. J. Clin. Oncol. 30 (2007) 368-376
18. Janicki-Deverts D., Cohen S., Doyle W.J., Turner R.B., and Treanor J.J. Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect. Brain Behav. Immun. 21 (2007) 301-307
19. Jehn C.F., Kuehnhardt D., Bartholomae A., Pfeiffer S., Krebs M., Regierer A.C., Schmid P., Possinger K., and Flath B.C. Biomarkers of depression in cancer patients. Cancer 107 (2006) 2723-2729
20. Kiecolt-Glaser J.K., McGuire L., Robles T.F., and Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu. Rev. Psychol. 53 (2002) 83-107
21. Kiecolt-Glaser J.K., Loving T.J., Stowell J.R., Malarkey W.B., Lemeshow S., Dickinson S.L., and Glaser R. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch. Gen. Psychiatry 62 (2005) 1377-1384
22. Knight R.G., William S., McGee R., and Olaman S. Psychometric properties of the Centre for Epidemiologic Studies Depression Scale (CES-D) in a sample of women in middle life. Behav. Res. Ther. 35 (1997) 373-380
23. Lutgendorf S.K., Johnson E.L., Cooper B., Anderson B., Sorosky J.I., Buller R.E., and Sood A.K. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95 (2002) 808-815
24. Lutgendorf S.K., Weinrib A.Z., Penedo F., Russell D., DeGeest K., Costanzo E.S., Henderson P.J., Sephton S.E., Rohleder N., Lucci J.A., Cole S., Sood A.K., and Lubaroff D.M. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J. Clin. Oncol. 26 (2008) 4820-4827
25. Marsland A.L., Cohen S., Rabin B.S., and Manuck S.B. Trait positive affect and antibody response to hepatitis B vaccination. Brain Behav. Immun. 20 (2006) 261-269
26. Marsland A.L., Pressman S., and Cohen S. Positive affect and immune function. In: Ader R. (Ed). Psychoneuroimmunology. fourth ed. vol. 2 (2007), Elsevier, San Diego, CA 761-779
27. Moskowitz J.T. Positive affect predicts lower risk of AIDS Mortality. Psychosom. Med. 65 (2003) 620-626
28. Moskowitz J.T., Epel E.S., and Acree M. Positive affect uniquely predicts lower risk of mortality in people with diabetes. Health Psychol. 27 (2008) S73-S82
29. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., Pearce B.D., Landry J., Glover S., McDaniel J.S., and Nemeroff C.B. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am. J. Psychiatry 158 (2001) 1252-1257
30. Okunieff P., Chen Y., Maguire D.J., and Huser A.J. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev. 27 (2008) 363-374
31. Petrini B., Andersson B., Strannegard O., Wasserman J., Blomgren H., and Glas U. Monocyte release and plasma levels of interleukin-6 in patients irradiated for cancer. In Vivo 6 (1992) 531-534
32. Pradhan A.D., Manson J.M., Rifai N., Buring J., and Ridker P. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
33. Prather A.A., Marsland A.L., Muldoon M.F., and Manuck S.B. Positive affective style covaries with stimulated IL-6 and IL-10 production in a middle-aged community sample. Brain Behav. Immun. 21 (2007) 1033-1037
34. Pressman S.D., and Cohen S. Does positive affect influence health?. Psychol. Bull. 131 (2005) 925-971
35. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. J. Appl. Psychol. Meas. 1 (1977) 385-401
36. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
37. Robles T.F., Brooks K.P., and Pressman S.D. Trait positive affect buffers the effects of acute stress on skin barrier recovery. Health Psychol. 28 (2009) 373-378
38. Ryff C.D., Singer B.H., and Dienerg Love G. Positive health: connecting well-being with biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 (2004) 1383-1394
39. Shacter E., and Weitzman S.A. Chronic inflammation and cancer. Oncology 16 (2002) 217-229
40. Sheehan T.J., Fifield J., Reisine S., and Tennen H. The measurement structure of the Center for Epidemiologic Studies Depression Scale. J. Pers. Assess. 64 (1995) 507-521
41. Steptoe A., O'Donnell K., Badrick E., Kumari M., and Marmot M. Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study. Am. J. Epidemiol. 167 (2008) 96-102
42. Stone H.B., Coleman C.N., Anscher M.S., and McBride W.H. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 4 (2003) 529-536
43. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-a double edged sword. Neuron 35 (2002) 419-432